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INTRODUCTION 
 
 
Tuberculosis, one of the oldest diseases known to mankind, continues to be a 
major public health problem in the world today , especially in developing countries 
like India. According to WHO, over one third population are at risk in developing 
tuberculosis today. Extrapulmonary TB constitutes only 10% of all cases of 
tuberculosis and cutaneous TB accounts to about 1.5% of all such cases. Improved 
living standards, effective screening and treatment have greatly reduced the 
prevalence of TB in industrialised countries but resurgence is being witnessed in 
developing countries.  
 
The factors responsible for resurgence are 
  
¾ overcrowding due to migration of infected people from areas of high prevalence to      
 
           low endemic areas 
 
¾ worsening urban economic and social environment 
 
¾ emergence of MDR  M.tuberculosis 
 
¾ increasing incidence of AIDS 
 
 
 
Though cutaneous TB constitutes only a minor proportion , bearing in mind the prevalence  
 
of TB,   these numbers become significant. Cutaneous TB can mimic the  
 
clinicopathological features of many  other skin diseases, and underlying systemic or organ  
 
TB can be difficult to detect, resulting in diagnostic challenges and pitfalls and potential  
 
delays in diagnosis and institution of treatment.  
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The varied clinicopathological features of cutaneous TB are attributed to 
 
¾ pathogenecity of organism 
 
¾ resistance of the organism   
  
¾ portal of infection 
 
¾ immune status of the host 
 
Cutaneous manifestations of TB include a wide and often overlapping spectrum of papules,  
 
pustules, papulonecrotic , nodular, verrucous lesions, panniculitis, plaques, ulcers, sinuses,  
 
scars.  
 
This study was undertaken to unravel the variations in morphology and  
 
clinicohistopathological correlation of various types of cutaneous TB. 
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AIM OF THE STUDY 
 
 
 
To find out the incidence of various morphological types and clinicohistopathological  
 
 
correlation of cutaneous TB presenting  to our department and to compare that in the  
 
 
 
literature. 
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REVIEW OF LITERATURE 
 
Just as systemic TB can be protean and diverse in its clinical manifestations, so  
 
tuberculosis of the skin is also highly variable in its clinical appearance, significance, and  
 
prognosis. 
 
 
 
Bacteriology 
 
The causative bacterium is Mycobacterium tuberculosis ,discovered by Robert koch in  
 
18823. It measures 2.5 to 3.5 µm in length by 0.3 to 0.6µm in width. 
 
This slightly curved ,sporeless,motile,obligate aerobic gram positive bacterium is acid  
 
and alcohol fast. 
 
          The cell wall of the mycobacterium contain mycolic acid which protects bacterium  
 
from cell lysosomal attack. Lipoarabinomannon is present in the plasma membrane.  
            
There are two types of M. TB involved in cutaneous TB – human (common) and bovine 
(rare). 
 
 
 
Epidemiology 
 
Cutaneous tuberculosis forms a small proportion of extra pulmonary TB. The incidence  
 
of cutaneous TB has fallen from 2% to 0.15% in India. But in the present scenario, the  
 
disease is fast reappearing due to HIV  pandemic and emerging MDR M.tuberculosis. 
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Disease transmission 
 
In pulmonary TB transmission is mainly by inhalation of airborne droplets and rarely by  
 
direct inoculation. the mode of infection in cutaneous TB may be exogenous (eg)  
 
autoinoculation, or endogenous (eg) extension of an underlying diseased organ or by  
 
lymphatic or haematogenous spread1. 
 
 
 
PATHOGENESIS AND IMMUNOLOGY 
 
Various factors involved in the pathogenesis are 
 
 
Infection and  invasion: 
 
The interaction of M.tuberculosis with the human host begins when droplet nuclei  
 
containing micro organisms from infectious patients are inhaled. 
 
 
Virulence of tubercle bacilli4: 
 
Several  genes are responsible for the virulence of the bacilli like 
 
     -  kat gene which encodes for catalase enzyme that protect against oxidative stress 
      
     - rpo V gene is the main factor initiating transcription of several genes 
    
     - erp gene encodes a protein required for multiplication 
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Innate resistance to infection: 
 
Polymorphisms in multiple genes, such as  those encoding for HLA, TGF- ß, IL-10,  
 
Mannose binding  protein, Toll like receptor 2, IL-2 have been associated with  
 
susceptibility to tuberculosis. Several genetic factors play a key role in innate nonimmune  
 
response to infection with M. tuberculosis. The NRAMP1 gene, which maps to  
 
chromosome 2q, may play a role in determining susceptibility to tuberculosis. 
 
 
Granuloma formation: 
 
With the development of specific immunity and the accumulation of large numbers of  
 
activated macrophages at the site of primary lesion, tubercles are formed. It consists of  
 
accumulation of lymphocytes and activated macrophages that evolve toward epitheloid  
 
and giant cell morphologies. 
 
 
  
Role of monocytes and macrophages: 
 
Cell mediated immunity confers partial protection against M. tuberculosis. Monocytes  
 
and macrophages , attracted  to the site , are the  key components of immune response.  
 
These cells produce nitric oxide and  cytokines, which has anti mycobacterial activity.  
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Role of T lymphocytes: 
 
Activated CD4+ T lymhocytes differentiate in to cytokine producing Th 1 or Th 2 cells. 
 
Th1 cells produce  IFN γ, which is activator of monocytes and macrophages. 
 
Th2 cells produce IL-4, IL-5, IL-10, IL-13. These cytokines promote intracellular killing  
 
of mycobacteria.  
 
 
Mycobacterial lipids and proteins: 
 
Lipids have been involved in mycobacterial recognition by innate immune system, and  
 
lipoproteins have been proven to trigger potent signals through TLRs , present in blood  
 
dendritic cells. M. tuberculosis possesses various protein antigens, which are important in  
 
eliciting a T lymphocyte response. Among the antigens that may play a protective role  
 
are the 30kDa and ESAT-6 antigens.    
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Schematic representation of pathogenesis of Cutaneous TB 
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CLASSIFICATION 
 
 
The most widely accepted classification for cutaneous TB is based on the mechanism of  
 
disease propogation as proposed by Beyt et al in  19816. 
 
1)Exogenous source                                   - Tuberculous chancre 
                                                                    
                                                                     -  warty tuberculosis 
                                                            
                                                                     -   Lupus vulgaris (some) 
 
2)Endogenous source 
                           
     Contiguous spread                                  -  Scrofuloderma 
     
     Autoinoculation                                      -  Orificial tuberculosis 
     
 
 
3) Hematogenous                                       -  Miliary tuberculosis 
                                                                   
                                                                     -  Lupus vulgaris                                                                
                                                                  
                                                                     -  Tuberculous gumma 
 
 
4)Eruptive tuberculosis 
     (tuberculids) 
       
Micropapular                                        -  Lichen scrofulosorum 
 
       Papular                                                 -   Papulonecrotic tuberculid 
  
           Nodular                                                -   Erythema induratum of Bazin ,  
     
                                                                            Erythema nodosum 
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    An additional classification system was designed based on bacterial load. This system is  
    
    extremely similar to Ridley and Jopling’s description of M.leprae in Hansen’s disease2.                
 
 
1) Multi bacillary form which contains abundant bacilli 
 
¾ Tuberculous chancre  
 
¾ Tuberculous Gumma 
 
¾ Acute miliary tuberculosis 
 
¾ Periorificial tuberculosis 
 
¾ Scrofuloderma 
 
2) Pauci bacillary form  
 
¾ Warty TB 
 
¾ Lupus vulgaris 
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TUBERCULOUS CHANCRE 
 
Synonynm: primary inoculation tuberculosis 
 
Definition: 
 
Tuberculous chancre develops as a result of inoculation of M.tuberculosis  in to the skin of  
 
an individual without any immunity to the organism. 
 
Pathogenesis: 
 
The inoculation occurs on the exposed areas, especially extremities and face, from cuts,  
 
abrasions, scratches, circumcision, ear piercing, tattooing, mouth to mouth respiration10.   
 
   
Clinical features : 
 
 After an incubation period of about 3-4 weeks following inoculation, a papule 
develops, which quickly breaks down to form an indolent ,firm, ragged ulcer with 
undermined edge and granular haemorrhagic base. Later it becomes firm and thin 
adherent crust develops11. Sometimes the initial lesion is small and characteristic 
apple-jelly nodules may be demonstrated.5 Three types of lesions have been 
described1 – chancriform type, impetigenous type and echthymatous type.The 
chancriform lesion has a  classic regional lymphadenopathy that occurs about 3-4 
weeks after the development of the ulcer. This may be seen with or without an  
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intervening lymhangitis, which may be tender and have cord-like induration. This 
primary complex has great diagnostic value.Inoculation about the nail may produce 
painless paronychia12. conjunctival edema and irritation have been described. Oral 
lesions are uncommon. 
 
 
 Tuberculin test: 
 
Tuberculin test negative early in the course of disease. 
 
 
Histopathology: 
 
 Aute neutrophilic reaction with areas of necrosis, ulceration and numerous bacilli present.  
 
After 3-6 weeks, due to development of immunity, the infiltrate becomes granulomatous. 
 
Epitheloid cells, Langhans giant cells and peripheral rim of lymphocytes are present. 
 
 
Course and prognosis: 
 
The chancre will heal slowly, taking many months, but may rarely proceed to lupus  
 
vulgaris. Erythema nodosum may occur in 10% cases13. In patients with poor immunity  
 
and high bacterial load, acute military tuberculosis can develop. 
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Differential diagnosis: 
 
In the early ulcerative phase, the diseases to be considered are the ulcerative pyodermas,  
 
atypical mycobacterial infections, chancre, cutaneous leishmaniasis ,cutaneous  
 
malignancies with local metastasis. 
 
 
 
 
 
 
WARTY TUBERCULOSIS 
 
  Synonyms:   Tuberculosis verrucosa cutis  
                        
                        Prosector’s wart   
                         
                       Verruca necrogenica  
                        
                       Post primary inoculation tuberculosis  
                        
                       Verrucous tuberculosis  
 
                        Anatomist’s wart 
 
 
Definition: 
 
It is an indolent, warty, plaque-like form of tuberculosis occurring as a result 
of inoculation of the organism in to the skin of a previously infected patient with 
moderate or high degree of immunity. 
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Pathogenesis: 
 
¾ Accidental  infection in phycicians, pathologists, lab workers, postmortem attendants14 
 
¾ Autoinoculation with sputum  in individuals with active tuberculosis      
 
¾ Children and young adults with moderate immunity,who come in contact with infected  
 
Material15 
 
 
 
Clinical features: 
 
 Lesions occur most on those areas exposed to trauma and to infected sputum or oter  
 
tuberculous material.  Commonly affected sites are the knees, ankles, buttocks16. The initial  
 
lesion is a painless, dusky- red papule that expands peripherally and is surrounded by an  
 
inflammatory halo. Irregular extension at the edges leads to serpiginous outline with  
 
finger-like projections. The centre may involute producing an atrophic scar. The  
 
consistency is firm and a probe cannot be passed.Beads of pus may be expressed from  
 
softer areas. Lymphadenopathy is characteristically rare or absent.  
 
 
 Unusual variants17 are 
                     
¾ Psoriasiform 
 
¾ Keloidal 
 
¾ Exudative 
 
¾ Ulcerative 
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¾ Granulomatous 
 
¾ Crusted 
 
¾ Deeply destructive papillomatous 
 
¾ Sclerotic forms. 
 
 
Tuberculin test: 
 
Tuberculin test is usually positive. 
 
 
          Histopathology: 
 
Epidermis shows hyperkeratosis, acanthosis, papillomatosis, pseudoepitheliomatous 
 
hyperplasia.Upper dermis shows abscess formation and tuberculoid granulomas  with a  
 
slight to moderate amount of caseation necrosis are present in the mid dermis. 
 
 
Course and prognosis: 
 
Spontaneous involution can occur over months to years resulting in atrophic  
 
scar18.Overall,the prognosis is good. 
 
 
Differntial diagnosis: 
 
Subungual and digital verruca, atypical mycobacterial infections, hypertrophic lichen  
 
planus, blastomycosis, chromoblastomycosis,tertiary syphilis, leishmaniasis. 
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SCROFULODERMA 
 
Synonym: Tuberculosis colliquativa  cutis 
 
 
Definition: 
 
 It results from involvement and breakdown of the skin overlying a contiguous tuberculous  
 
focus which is usually a lymph gland, infected bone or joint, lacrimal gland or duct19. 
 
 
Pathogenesis: 
 
It usually extends from underlying infected lymph node, but also may present as an  
 
extension of disease from an underlying infected joint, tendon, bursa, bone, or tuberculous  
 
epididymitis. In children, the infection is mainly due to bovine tubercle bacillus as a result  
 
of tonsillar infection. 
 
 
Clinical features: 
 
The initial lesion is a firm, subcutaneous or deep cutaneous nodule which later ulcerates.  
 
The ulcer has a bluish undermined edge with granulating tissue at the base. Fistulae and  
 
sinuses may be formed beneath ridges of a bluish skin. Multiple lesions may be produced  
 
following haematogenous dissemination. Cervical nodes are most commonly affected  
 
followed by axillary, inguinal, epitrohlear, retro auricular nodes20. it is the commonest form  
 
of cutaneous tuberculosis in Indian children21. As a result of progression and scarring,  
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irregular cicatricial bands may be produced. Fungating tumours may develop due to  
 
excessive granulation tissue and secondary bacterial infections. After healing,  
 
characteristic puckered scarring occur23. 
 
 
Tuberculin test : 
 
Strongly positive 
 
 
Histopathology: 
 
Epidermis shows ulceration and necrosis.Dermis shows an ulcerated abscess with marked  
 
caseation necrosis. Numerous bacteria can be demonstrated. 
 
 
 
Course and prognosis: 
 
Spontaneous healing can occur, but the course is very protracted and leaves typical cord- 
 
like structures. Lupus vulgaris can develop from the scar of scrofuloderma. Malignant  
 
change in the form of epithelioma can occur. 
 
 
Differential diagnosis: 
 
Atypical mycobacterial infections, tularemia, lymphopathia venerum, actinomycosis,  
 
nocardiosis, hidradenitis suppurativa, syphilitic gumma, acne conglobata. 
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ORIFICIAL TUBERCULOSIS 
 
Synonyms: Acute tuberculous ulcer 
 
                    Tuberculosis cutis orificialis 
 
 
Definition: 
 
Tuberculous infection of mucous membrane and skin of orifices, resulting from  
 
auto inoculation of the tubercle bacilli in patients with advanced visceral tuberculosis. 
 
 
Pathogenesis: 
 
This is normally a form of autoinoculation tuberculosis, although extraneous sources are  
 
occasionally responsible24. the lesions occur in advanced pulmonary, intestinal or  
 
genitourinary disease. 
 
 
Clinical features: 
 
Ulcerative lesions occur in the oral cavity, perianal and perirectal areas. The tip and  
 
lateral margins of the tongue are most commonly involved. The initial lesion is a small,  
 
yellowish or reddish nodule that rapidly breaks down to form an exquisitely painful,  
 
shallow ulcer with bluish, undermined edges. 
 
 
Tuberculin test: 
 
Usually anergy present due to lowered immunity. 
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Histopathology: 
 
Non specific. Inflammatory infiltrate with pronounced necrosis  present in lower dermis.  
 
Numerous bacilli can be demonstrated. 
 
 
Course and prognosis: 
 
No tendency for spontaneous healing and has a poor prognosis. 
 
 
          Differential diagnosis: 
 
Syphilitic chancre, luetic gumma, aphthosis, deep mycosis, granulomatous vasculitis, local  
 
or metastatic malignancy. 
 
 
 
LUPUS VULGARIS 
 
Synonym – Tuberculosis cutis luposa 
 
 
Definition: 
 
A chronic progressive post primary form form of cutaneous tuberculosis in an individual  
 
with moderate or high degree of immunity. 
 
 
Pathogenesis: 
 
It can arise by contiguous, lymphatic or hematogenous spread. It may develop at the site of  
 
tuberculous chancre, in the scar of scrofuloderma, BCG vaccination scar25. 
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Clinical features: 
 
The initial lesion is a small, reddish- brown, flat plaque of soft, almost gelatinous  
 
consistency. On diascopy, the characteristic apple jelly nodules can be demonstrated. The  
 
lesion extends peripherally with central atrophy or scarring. The reactivation of nodules  
 
within previously atrophic or scarred areas is characteristic. Multiple lesions are  
 
uncommon. Probe can be easily passed as it is soft in consistency.Females are more  
 
commonly affected than males. In India, face is affected less commonly and buttocks and  
 
trunk more frequently26. Mucosal involvement involving nasal, buccal or conjunctival  
 
mucosa can occur. 
 
Clinical variants:  
 
¾ plaque type with psoriasiform scaling 
 
¾ ulcerative and mutilating type- scarring and ulceration predominate. Crusts form over  
 
       areas of necrosis. Contractures and deformities can develop. 
 
¾ vegetating form or lupus vegetans or lupus papillomatosus- characterized by marked  
 
  infiltration, ulceration and necrosis. Mucous membrane and cartilage are involved  
 
  resulting    in extensive destruction. 
 
¾ lupus vulgaris verrucosus 
 
¾ lupus vulgaris involving mucous membrane or lupus vorax 
 
¾ lupus postexathematicus- due to lowered immunity following a viral exanthem   
 
 
 
20 
 
 
 
 
¾ tumour-like form- presents as hypertrophic or myxomatous forms which may cause  
 
   lymphedema and vascular dilatation. 
 
¾ papular and nodular forms- multiple lesions occur in disseminated lupus- true military  
 
  lupus 
 
¾ sporotrichoid form 
 
 
 
           Tuberclin test: 
 
Usually positive. 
 
 
Histopathology: 
 
Epidermis is normal or ulcerated or atrophic or acanthotic with pseudoepitheliomatous  
 
hyperplasia.Upper dermis shows well formed granulomas, composed of epitheloid cells,  
 
Langhan giant cells and lymphocytes. Caseation necrosis is absent or minimal. Bacilli  
 
usually not found. 
 
 
Course and prognosis: 
 
Lupus vulgaris can be a very protean, destructive disease. It progresses slowly over years,  
 
without treatment. Severe scarring, disfigurement and mutilation can occur. Long  
 
standing cases can be complicated by squamous cell carcinoma, basal cell  
 
carcinoma,sarcoma. Hodgkin’s disease. 
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Differential diagnosis: 
 
Leishmaniasis, sarcoidosis, facial granulomas, erythema elevatum diutinum, leprosy, 
psoriasis,  
 
Bowen’s disease, halogenodermas, blastomycosis, lupus pernio, rhinoscleroma. 
 
 
 
 
MILIARY TUBERCULOSIS 
 
Synonyms: Haematogenous primary tuberculosis 
      
                    Miliaris disseminatus 
 
 
 
Definition: 
 
 It occur in association with generalized military tuberculosis and is due to haematogenous  
 
dissemination of mycobacteria into skin. 
 
 
Pathogenesis: 
 
It is rare and usually occur and usually occur in young children or immunosuppressed 
patients27. 
 
 
Clinical features: 
 
The primary lesions are discrete, pinhead-sized, bluish- red macules or papules or  
 
vesicles, which soon  burst and form crusts. Ulcerations, subcutaneous nodules, purpuric  
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lesions can also occur. 
 
 
Tuberculin test: 
 
Always negative. 
 
 
Histopathology: 
 
Focal areas of necrosis and abscess formation  containing numerous bacilli. 
 
 
         Course and prognosis: 
 
Poor prognosis and death is due to overwhelming infection. 
 
 
 
TUBERCULOUS GUMMA 
 
Synonym: Metastatic tuberculous abscess 
 
 
Definition: 
 
 It result from hematogenous dissemination from primary focus during periods of lowered  
 
resistance, resulting in single or multiple lesions. It is  seen in malnourished children,after  
 
local trauma and in association with underlying lymphoma. 
 
 
Clinical features: 
 
Presents as a firm , subcutaneous nodule in extremities. Later it forms abscess, which  
 
breaks down to form an undermined ulcer with sinuses. Lesions may occur in  
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          sporotrichoid fashion. 
 
 
Tuberculin test:  
 
Modest sensitivity. 
 
 
Differential diagnosis: 
 
Syphilitic gumma, subcutaneous bacterial, mycotic lesions, panniculitides 
 
 
 
RARE FORMS OF CUTANEOUS TUBERCULOSIS 
 
 
          Tuberculosis fungosa serpiginosa: 
 
It is a very rare chronic form ofskin tuberculosis, which occurs in anergic,elderly  
 
individuals via exogenous or endogenous inoculation. Patients present with thick,  
 
papillomatous, vegetative, noncornified plaques, commonly in the axilla and dorsum of  
 
hands.Numerous bacilli can be found in the lesions. Tuberculin test is negative. 
 
 
         Iatrogenic immunization tuberculosis: 
 
Lupus vulgaris,scrofuloderma,acute military tuberculosis can develop following BCG  
 
vaccination. Since BCG organism is an attenuated M.tuberculosis bovis, it can behave as  
 
a virulent opportunistic pathogen whenever immunity is suppressed. 
 
          Tuberculous mastitis: 
 
Patients present with nontender cold abscess in the breast. 
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TUBERCULIDS 
 
A tuberculid is a cutaneous immunological reaction to the presence of occult TB in a  
patient with moderate to high immunity.                                                                                              
The main features of tuberculids as first described by Jean Darier in 189628,are 
¾ positive tuberculin skin test   
¾ tuberculous involvement of lymph nodes,viscera or both 
¾ absence of tubercle bacilli in the lesion  
¾ skin lesions that heal on remission of the tuberculous infection. 
 
LICHEN SCROFULOSORUM 
Synonym: Tuberculosis cutis lichenoides 
Definition and pathogenesis: 
First described by Hebra. It is a lichenoid eruption occurring in children and adolescents.  
Its onset may be linked to an up-regulation in immune status30. 
Clinical features: 
The eruption is characterized by asymptomatic, pin-head sized, lichenoid or skin  
coloured, follicular or perifollicular papules. Common sites are abdomen, chest, back and  
proximal limbs. 
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Tuberculin test: 
Always positive. 
 
Histopathology: 
Superficial dermal granulomas around hair follicles and sweat ducts. Epitheloid cells,  
lymphocytes and occasional giant cells are seen. 
 
Course and prognosis: 
Spontaneous resolution can occur but recurrences are possible. 
 
Differential Diagnosis: 
Lichenoid id, secondary eruptions of treponemal infections, lichen nitidus, eruptive  
syringoma, and a drug eruption. 
 
PAPULONECROTIC TUBERCULID 
Synonym: tuberculosis cutis papulonecrotica 
 
Definition and pathogenesis: 
It is an eruption of necrotizing papules affecting the extensor aspect of extremities and is  
associated with deep focus of tuberculosis. 
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 Clinical features; 
The eruption consists of  recurring crops of symmetrical, hard,dusky-red papules. These  
crust, ulcerate, leaving atrophic, varioliform scars31. Young adults are affected. Most  
common sites are legs, knees, elbows, buttocks, penis.  
 
Tuberculin test: 
Strongly positive. 
 
Histopathology: 
Leukocytoclastic vasculitis is present in early cases. Later, wedge-shaped necrosis  
develops. Epitheloid cells and giant cells are seen at the periphery of necrotic zone. Blood  
vessel involvement is a key feature. 
 
 
Course and prognosis; 
  
Disease may last for years or decades with recurrent crops of ulceration and consequent  
 
varioliform scarring. 
 
 
Differential Diagnosis: 
 
Pityriasis lichenoides, leukocytoclastic vasculitis, nodular prurigo. 
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ERYTHEMA INDURATUM OF BAZIN 
 
Synonym: Bazin’s disease 
                  
                  Tuberculosum 
                   
                  Tuberculosis cutis indurativa 
                   
                   Nodose tuberculid 
 
 
Definition and pathogenesis: 
 
It is characterized by inflammatory cutaneous and subcutaneous nodules in an individual  
 
with past or active tuberculosis. It is believed to be an allergic or hypersensitivity reaction  
 
to tubercle bacilli32. 
 
 
Clinical features: 
 
Symmetrical, tender, firm, well circumscribed nodules. Lesions may ulcerate following  
 
cold exposure. The ulcers are ragged, irregular, shallow with a bluish edge. Typically  
 
affects the calves of pubertal or adult women33. 
 
  
Tuberculin test: 
 
Strongly positive. 
 
 
          Histopathology: 
 
Early stage - inflammation of vessel wall with lymphocytic and plasma cell infiltrate 
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                       with thickening of  adventitia and media. Perivascular infiltrate is present. 
 
                              - A septal panniculitis is present, which may overflow in to the fat lobules. 
 
                   - A lobular granulomatous reaction develops which may lead to atrophy of fat      
                      
                     tissues34,35. 
 
Late stage   -  caseation and liquefaction develop and fibrosis occur. 
 
 
Course: 
 
May wax and wane for many years. Good prognosis is expected if no general disease is  
 
found. 
 
              
              
     ERYTHEMA NODOSUM 
 
 
Definition and pathogenesis: 
 
It is an acute, nodular, erythematous eruption that is usually limited to the extensor  
 
aspects of the lower legs, with occasional spread to thighs or arms. It is presumed to be a  
 
hypersensitivity reaction and may occur in association with tuberculosis36. 
 
          Other triggering factors 
 
1) sarcoidosis  
 
2) inflammatory bowel disease 
 
          3) infections   
 
4) drug therapies  
 
5) idiopathic in 70% of cases. 
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Clinical features: 
 
It is the most common panniculitis in India. Erythema nodosum may occur in children 
 
and patients older than 70 years, but it is more common in young adults aged 18-34 years.  
 
As a manifestation of tuberculosis, erythema nodosum has been described in children  
 
with primary tuberculosis infection and may be associated with phlyctenular  
 
conjunctivitis. Low grade fever and swelling of the ankle joints accompany  
 
the skin lesions in some patients. Immune complex deposition within dermal vessels is an  
 
important component in the production of the symptom complex. Patients usually present  
 
with skin rash in the form of dusky red, tender and nodular lesions. Lesion borders are  
 
poorly defined and size vary from 2-6 cm. Individual lesions last approximately two  
 
weeks, but occasionally, new lesions continue to appear for three to six weeks. Arthralgia  
 
occurs in more than 50% of patients and begins during the eruptive phase or precedes the  
 
eruption by 2-4 weeks. Any joint may be involved, but the ankles, knees, and wrists are  
 
affected most commonly. No destructive joint changes occur. Synovial fluid is acellular,  
 
and the rheumatoid factor is negative. When erythema nodosum is diagnosed, it is  
 
important to find out the underlying conditions. 
 
 
          Tuberculin test: 
 
 The tuberculin skin test is always strongly positive and a negative skin test rules out  
 
 tuberculosis as the etiology. 
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Histopathology:  
 
Histopathologically, erythema nodosum is the stereotypical example of a mostly septal  
panniculitis with no vasculitis6. The septa of subcutaneous fat are always thickened and  
variously infiltrated by inflammatory cells that extend to the periseptal areas of the fat  
lobules. Usually, a superficial and deep perivascular inflammatory infiltrate  
predominantly composed of lymphocytes is also seen in the overlying dermis. This  
dermal inflammation along with vasodilatation probably accounts for the erythematous  
appearance of early lesions, whereas the changes in the subcutis are responsible for the  
nodularity of the lesions on palpation. A histopathologic hallmark of erythema nodosum  
is the presence of the so-called Miescher's radial granulomas6, that consist of small, well- 
defined nodular aggregations of small histiocytes around a central stellate or banana  
shaped cleft .   In early lesions, Miescher's radial granulomas appear scattered in the septa  
and surrounded by neutrophils. In older nodules of erythema nodosum, histiocytes  
coalesce to form multinucleated giant cells, many of which still retain in their cytoplasm  
a stellate central cleft reminiscent of those centers of Miescher's radial granuloma .  
Miescher's radial granulomas are present in all stages of the evolution of erythema  
nodosum lesions and they should be searched for in order to make a specific diagnosis.  
 
Course and  prognosis:  
 
Erythema nodosum tends to disappear by itself and often does not need any specific  
 
treatment. Generally, the prognosis of erythema nodosum is very good. 
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CRITERIA FOR DIAGNOSIS OF CUTANEOUS TUBERCULOSIS 
 
 
Major criteria: 
 
 
¾ Culture for AFB positive 
 
 
¾ Positive animal inoculation 
 
 
¾ PCR positive 
 
 
 
Minor critera: 
 
 
¾ Compatible histopathology 
  
 
¾ AFB in the lesion 
 
 
¾ Positive tuberculin test 
 
 
¾ Active visceral tuberculosis 
 
 
¾ Raised ESR  
 
      
¾ Response to 6 weeks of trial with anti tuberculous therapy  
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DIAGNOSIS 
 
 
A  clinical diagnosis of cutaneous tuberculosis can be made confidently in most instances  
 
but requires confirmation by any of the following investigations. 
 
 
 
CULTURE METHODS3 
 
Can be either solid or liquid media 
 
Solid media 
  
Lowenstein-jensen medium is the most well known medium 
  
Specimen may be inoculated in to the medium and incubated at 37°c. growth detected  
 
after4-8 weeks. 
       
Liquid media 
 
A number of commercial liquid-based  mycobacterial culture systems include BACTEC  
 
460 TB system , BACTEC Mycobacterial Growth Indicator Tube 960 system. 
 
The medium contains radiolabelled palmitic acid as a sourceof carbon and this is  
 
metabolized by the growing organisms. The amount of carbondioxide emitted is monitered  
 
by repeated aspiration of the atmosphere in each vial to detect its growth. Growth can be  
 
detected in 10-22 days and the recovery rate is 88%-100%. 
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Identification from culture is by performing Ziehl-Neelson staining or auromine- 
 
rhodamine staining. 
 
Other methods like 
 
1) niacin test  
 
2) mycolic acid analysis by high-performance liquid chromatography ,  
 
3) genotype assays  
 
can also be employed for detection of mycobacterium in culture. 
 
 
 
PCR37 
 
 
Polymerized chain reaction DNA amplification by PCR is another rapid, sensitive  
 
method that has been used to detect cutaneous TB in several studies, most commonly  
 
targeting the IS6110 gene specific for the  M.tuberculosis complex. However, PCR is a  
 
labor-intensive technique and is susceptible to several technical errors. It may provide  
 
false-positive results by carry-over contamination. False-negative results may be caused  
 
by degraded target DNA, the presence of PCR-inhibiting substances in clinical samples  
 
or insufficient extraction of target DNA. Moreover, it cannot be used to test drug  
 
susceptibility. Finally, the high cost of this technique becomes prohibitive for its use,  
 
especially in a resource-poor country like India. 
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HISTOPATHOLOGY39 
 
The hallmark of cutaneous tuberculosis is the presence of tuberculous or tuberculoid  
 
granuloma.  
 
Seven patterns have been described: 
 
1) Classic tuberculoid granulomas, which consist of typical granulomas with Langhans  
 
giant cells. A   peripheral cuff of lymphocytes surrounds the giant cells. Caseation  
 
necrosis may or may not be present. 
 
2) Abscess formation,which consists of acute or chronic inflammatory cells with variable  
 
degree of  necrosis. Giant cells are seen only in few cases. 
 
3) Diffuse infiltration of histiocytes with few other inflammatory cells. Only a few well  
 
formed granulomas  are seen. Necrosis is universal.   
 
4) Panniculitis involving both seta and lobules. Abscess formation and necrosis can  
 
occur. Phlebitis can be   found rarely.  
 
5) Nonspecific chronic inflammation, which includes sheets or scattered clusters of  
 
chronic inflammatory cells consisting predominantly of lymphocytes and histiocytes.  
 
Plasma cells and eosinophils can also be seen. Giant cells are absent. 
 
6) Sarcoidal granulomas  - naked granulomas. Consist mainly Langhans giant cells, no  
 
peripheral rim of  lymphocytes. Necrosis is minimal or absent. Lamellar calcifications  
 
identical to Schaumann bodies are sometimes present. 
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7) Rheumatoid nodules, the hallmark of which is the presence of central necrosis  
 
surrounded by palisading  histiocytes, in the dermis or subcutis.  
 
 
 
MYCO DOT TEST41 
 
 
Mycobacteria are known to have several immunologically active antigenic components  
 
like 38 Kd antigen, 30 Kd antigen, 16 Kd antigen, A60 antigen and lipoarabinomannan  
 
(LAM). The MycoDot test is a new simple, rapid (20 minutes) and reliable serodiagnostic  
 
technique that can detect anti-mycobacterial antibodies in the serum or blood. It offers a  
 
low cost, single visit aid in the diagnosis of tuberculosis, with good sensitivity and  
 
excellent specificity .  
                 
                            The MycoDot test employs lipoarabinomannan (LAM) antigen which is  
 
bound to plastic combs. When the combs are incubated in diluted serum/blood, specific  
 
anti-LAM antibodies from the sample, if present, bind to the antigen. The sensitivity of  
 
the test is calibrated so that only cases of active mycobacterial diseases such as  
 
tuberculosis will generate a colored spot, which is as strong as or stronger than the  
 
weakest positive spot on the reference comb that is provided as a guide to interpret  
 
results. Healthy infected and/or BCG vaccinated individuals react negatively. 
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 IMMUNE-BASED TESTS5 
 
I)Tuberculin sensitivity test or Mantoux test3 
  
 History: 
 Tuberculin is a glycerol extract of the tubercle bacillus. Purified protein derivative (PPD)  
tuberculin is a  precipitate of non-species-specific molecules obtained from filtrates of  
sterilized, concentrated cultures. It  was first described by Robert Koch in 1890. The test  
is named after Charles Mantoux, a French physician  who developed on the work of Koch  
and Clemens von Pirquet to create his test in 1907. 
 
 Procedure 
 The suitable dilution of standard dose of tuberculin (standard dose 5TU) is injected in  
the inner aspect of forearm. A weal of 5mm should be raised. The     reaction is read after  
48 to 72 hours. The induration is  measure not the redness (erythema) surrounding it. 
 
 Dosage of tuberculin 
  The dose is 0.1ml. 
  In 0.1 ml of diluent contains 0.0001mg of Purified protein derivative (PPD) which is  
  equivalent to 5Tuberculin units (TU). 
  PPD is obtained by culturing Mycobacterium tuberculosis H37RA strain with TWEEN      
  80 on a protein free  medium Quinsol. 
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 If a person has had a history of a positive tuberculin skin test, or has not had a recent  
tuberculin skin test  (within one year), another skin test may be needed; if negative. 
 
Interpretation of tuberculin reaction 
 
 The results of this test must be interpreted carefully. The person's medical risk factors  
determine at which increment (5 mm, 10 mm, or 15 mm) of induration the result is  
considered positive.A positive result  indicates TB exposure. 
• 5 mm or more is positive in  
- HIV-positive person  
               - Recent contacts of TB case  
- Persons with nodular or fibrotic changes on chest x-ray consistent with old healed TB  
- Patients with organ transplants and other immunosuppressed patients  
• 10 mm or more is positive in  
- Recent arrivals (less than 5 years) from high-prevalence countries  
- Injection drug users  
- Residents and employees of high-risk congregate settings (e.g., prisons, nursing homes,     
   hospitals, homeless shelters, etc.) 
- Persons with clinical conditions that place them at high risk 
- Children less than 4 years of age, or children and adolescents exposed to adults in high-            
   risk  categories  
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• 15 mm or more is positive in  
- Persons with no known risk factors for TB   
A tuberculin test conversion is defined as an increase of 10 mm or more within a 2-year  
period, regardless of age. 
 
False positive result 
 
Due to the test's low specificity, most positive reactions in low-risk individuals are false- 
positives. A false positive result may be caused by nontuberculous mycobacteria or  
previous administration of BCG vaccine.  
Prior vaccination with BCG may result in a false-positive result for many years  
afterwards. 
 False positives can also occur when person touches the injected area, causing swelling  
and itching. 
 
False negative result 
 
Those that are immunologically compromised, especially those with HIV and low CD4 T   
cell counts, frequently show negative results from the PPD test. This is because the  
immune system needs to be functional to mount a response to the protein derivative  
injected under the skin. 
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Anergy testing 
 
 In cases of anergy, a lack of reaction by the body's defence mechanisms when it comes  
into contact with foreign substances, the tuberculin reaction will occur weakly, thus  
compromising the value of Mantoux testing. For example, anergy is present in AIDS, a  
disease which strongly depresses the immune system.  Therefore, anergy testing is  
advised in cases where suspicion is warranted that it is present. However,  routine anergy  
skin testing is not recommended. 
 
II)Interferon-gamma release assays (IGRA)4 
 
 Used in the diagnosis of latent TB infection. 
 
 Antigens used: 
 
 1) Early secreted antigenic target 6 (ESAT-6) 
 2) Culture filtrate protein 10 (CFP-10) 
 3) TB7.7 
 
          Commercially available IGRAs 
 
 1) Quanti-FERON  TB Gold assay 
 2) T-SPOT test  
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 QUANTI-FERON-TB GOLD IN-TUBE42 (QFT-IT) 
 
 This in vitro interferon-gamma-release assay is useful in the diagnosis of  tubercular  
infection. It is considered to be superior to tuberculin skin testing owing to its higher  
specificity.  In fact, in a rural and  predominantly BCG-vaccinated pediatric population in  
India, the tubercular skin test and QFT-IT assay were found to produce comparable   
results in the diagnosis of tubercular infection without any obvious advantage of the  
latter. 
 
 
ANTITUBERCULAR DRUG TRIAL43 (THERAPEUTIC TRIAL) 
 
The concept of therapeutic challenge as a valid diagnostic method in doubtful cases of  
cutaneous TB (where laboratory results are equivocal) has been corroborated in adults,  
and can be extended to the pediatric population as well. Four-drug antitubercular (ATT)  
therapy (consisting of isoniazid, rifampicin, pyrazinamide and ethambutol) is initiated  
and the clinical response is assessed in 4-6 weeks. If there is no significant response by 5  
weeks, it is unlikely that further treatment may be beneficial. In such a case, either the  
diagnosis should be reviewed or possibility of MDR TB should be considered. However,  
patients with tuberculids and those with minimally active disease may take longer than 5  
weeks to respond, and thus it may be worthwhile to prolong the therapeutic trial in such  
cases before considering alternative diagnoses.  
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TREATMENT  
 
Cutaneous TB is treated as per the recommendations of therapy for extrapulmonary TB44 
(category 3).  
Apart from the investigations to establish the diagnosis of cutaneous TB, HIV testing  
should be carried out in all patients with confirmed or suspected TB because their HIV  
status makes a difference to their antitubercular treatment.  
 
 
Classification of anti tubercular drugs: 
 
First line drugs: 
 
1) Ethambutol - EMB or E, 
2) Isoniazid - INH or H, 
3) Pyrazinamide - PZA or Z, 
4) Rifampicin -RMP or R, 
5) Streptomycin - STM or S. 
 
Second line drugs: 
 
There are six classes of second-line drugs (SLDs) used for the treatment of TB. A drug  
may be classed as second-line instead of first-line for one of three possible reasons: it  
may be less effective than the first-line drugs (e.g., p-aminosalicylic acid); or, it may have  
toxic side-effects (e.g., cycloserine) 
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1) Aminoglycosides: e.g., amikacin (AMK), kanamycin (KM); 
2) Polypeptides: e.g., capreomycin, viomycin, enviomycin; 
3) Fluoroquinolones: e.g., ciprofloxacin (CIP), levofloxacin, moxifloxacin (MXF); 
4) Thioamides: e.g. ethionamide, prothionamide 
5) Cycloserine (the only antibiotic in its class); 
6) p-Aminosalicylic acid (PAS or P). 
 
Third line drugs: 
Other drugs that may be useful are 
1) Rifabutin 
2) Macrolides: e.g., clarithromycin (CLR); 
3) Linezolid (LZD); 
4) Thioacetazone (T); 
5) Thioridazine; 
6) Arginine; 
7) Vitamin D; 
 
Standardized Treatment Regimens are one of the pillars of the DOTS strategy 
 
Isoniazid, Rifampicin, Pyrazinamide, Ethambutol, and Streptomycin are the primary  
antitubercular drugs used. Most DOTS regimens have thrice-weekly schedules and  
typically last for 6 months, with an initial Intensive phase and a Continuation  
phase.Based on the nature/severity of the disease and the Patients' exposure to previous  
anti-tubercular treatments,  
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RNTCP classifies tuberculosis patients in to three Treatment Categories37. 
 
Category I 
 
Category II 
 
Category III 
New sputum smear-
positive 
 
Seriously ill sputum 
smear-negative 
 
Seriously ill extra-
pulmonary 
 
New Sputum 
Positive/Negative 
HIV Positive 
Sputum smear-positive Relapse 
Sputum smear-positive Failure 
Sputum smear-positive Treatment 
after default 
Sputum smear negative 
Others/Chronic 
New sputum 
smear-negative, 
not seriously ill 
New extra-
pulmonary, not 
seriously ill 
 
2H3R3Z3E3 + 4H3R3 
2H3R3Z3E3S3 + 1H3R3Z3E3 + 5H3R3E3 2H3R3Z3 + 4H3R3
 
2 months Intensive 
phase + 4 months 
continuation phase 
 
Four drugs at 
Thrice-weekly 
Schedule 
3 months Intensive phase + 5 months 
continuation phase 
Five drugs at Thrice-weekly Schedule
2 months 
Intensive phase + 
4 months 
continuation 
phase 
Two drugs at 
Thrice-weekly 
Schedule 
H: Isoniazid (600 mg), R: Rifampicin (450 mg), Z: Pyrazinamide (1500 mg),  
E: Ethambutol (1200 mg), S: Streptomycin (750 mg) 
 
 
44 
PREVENTION 
 
BCG vaccination45 
Bacillus Calmette-Guérin (or Bacille Calmette-Guérin, BCG) is  
a vaccine against tuberculosis that is prepared from a strain of the attenuated (weakened)  
live bovine tuberculosis bacillus, Mycobacterium bovis that has lost its virulence in  
humans by being specially cultured in an artificial medium for years. The bacilli have  
retained enough strong antigenicity to become a somewhat effective vaccine for the  
prevention of human tuberculosis. At best, the BCG vaccine is 80% effective in  
preventing tuberculosis for a duration of 15 years. 
 
Description: 
 
BCG Vaccine is a live freeze-dried vaccine derived from attenuated strain of  
mycobacterium bovis. (Bacillus Calmette Gueri) used for the prevention of tuberculosis. 
 
 
Composition: 
 
Live, attenuated BCG Vaccine (Bacillus Calmette Gueri strain) 
Each 0.1 ml contains between: 1x105 and 33x105 C.F.U. 
Reconstitute with Sodium Chloride Injection 
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 Dosage and administration: 
 
The vaccine is intended to be injected strictly via the intradermal route, avoiding the  
subcutaneous route.The vaccination dose is 0.05 ml for children under one year of age  
including the new born, of the reconstituted vaccine given intrademally. The skin should  
not be cleaned with antiseptic. The vaccine should be preferably given with a tuberculin  
syringe or 25G/26G sterile needle and syringe.Skin testing with tuberculin is not  
generally carried out before giving BCG, but when performed, those who are found to be  
positive reactors need not to be immunised.  
 
Indications and immunization schedule: 
 
BCG Vaccine should be given routinely to all infants at risk of early exposure to  
tuberculosis. This vaccine should be given soon after the child is born. BCG administered  
early in life provides high level of protection particularly against sever forms of  
childhood tuberculosis and tubercular meningitis. In countries with low prevalence of  
tuberculosis, BCG vaccination should be restricted to high-risk groups such as hospital  
personnel and tuberculin negative contacts of known cases of tuberculosis. The vaccine  
can be given simultaneously with DTP, DT, TT, Measles, Polio and Hepatitis B vaccines,  
but at a separate site. 
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Adverse effects: 
 
Adverse events occur in 1-10% of individuals who receive BCG and vary depending  
upon dosage, method of administration and age of vaccine46. Lymphadenitis can also  
occur.  
- Lymphangitis can occur if the vaccine is administered too close to the shoulder and is  
characterized by streaking from site of injection towards the regional lymph nodes.   
- Lymphadenopathy of regional lymph nodes, which resolves spontaneously, occurs  
occasionally in young children. 
-  Osteomyelitis has been reported to occur rarely (one case per million vaccines) and most  
frequently in neonates.  
- Disseminated BCG infection, which can be fatal, occurs rarely in 1-10 cases per 10  
million vaccines and is more common in immunodeficient children. 
 
Skin Complications: 
Local  
¾ Keloid  
¾ Large ulcer 
¾ Subcutaneous abscess 
¾ Epithelial cyst 
¾ Granulomatous reaction  
¾ Lupus vulgaris 
¾ Warty TB 
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Generalized  
¾ Erythema nodosum 
¾ Tuberculids 
¾ Scrofuloderma 
¾ Nonspecific haemorrhagic eruption 
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MATERIALS AND METHODS 
 
Background 
 
Resurgence of tuberculosis in the era of HIV has rejuvenated the interest in this global  
problem. Moreover there is increased incidence of tuberculosis, due to multidrug resistant  
strains of M.tuberculosis. Transmission of cutaneous tuberculosis is facilitated by  
overcrowding, malnutrition and low socio economic status. Though the incidence of  
Cutaneous tuberculosis is low worldwide it is  increasing in developing countries like  
India.  
         This study is undertaken to unravel the variations in morphology and histopathology  
of Cutaneous tuberculosis and create awareness about Cutaneous tuberculosis. 
 
Study Design: 
 Prospective Study 
 
Study Procedure: 
Patients attending Dermatology OPD,Govt Stanley hospitals with clinical suspicion of  
cutaneous tuberculosis,  who are histopathologically proven , will be included in this  
study. 
 
Study Duration: 
One Year-May 2009 to April 2010 
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INVESTIGATIONS 
 
Patients included in this study wer subjected to the following investigations\ 
 
¾ Total count 
 
¾ Differential count 
 
¾ ESR 
 
¾ Haemoglobin% 
 
¾ Mantoux test 
 
¾ Sputum for AFB 
 
¾ Chest X-ray 
 
¾ Skin biopsy 
 
¾ Elisa for HIV 
 
¾ Screening forVDRL 
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 RESULTS 
 
Out of 30 cases studied, males were found to be more commonly affected than  
females.There were 16 males, 12 females and 2 male children. Depending upon  
morphological features and histopathological features, 30 cases were typified and of this 
 14 cases had warty tuberculosis,  
 9 cases had lupus vulgaris, 
2 cases had scrofuloderma   
2 cases had papulonecrotic tuberculid 
2 cases had erythema nodosum and 
1 was a case of lichen scrofulosorum.     
 
Histopathological correlation was present in all cases except a case of scrofuloderma,  
 
which showed only ulceration of the epidermis and few lymphocytic infiltrate in the  
 
dermis. Patients with warty TB showed characteristic tuberculoid granulomas(11 cases) in  
 
the mid dermis and epidermal changes were present in 10 cases. Out of 9 cases of lupus  
 
vulgaris epidermal changes were present in 4 cases, characteristic tuberculoid granulomas  
 
was present in 3 cases, Langhans giant cells were present in 4 cases. Ziehl-Neelson stain  
 
was performed on all cases but could demonstrate AFB only in one case of scrofuloderma.   
 
AFB culture was done in 2 cases of scrofuloderma and the result was negative in both  
 
cases. 
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Chest x-ray finding consistent with tuberculosis was present in 10 cases. Of this hilar  
 
adenitis was present in 3 cases, apical opacity was present in 2 cases. Mantoux was present  
 
in all cases except one case of scrofuloderma, which may be due to anergy. 
 
 
 
        The highest age incidence was found to be between 20 – 30 years and most of the  
 
patients with cutaneous TB, who were included in the study were males. Of the 30 cases  
 
studied, lymphadenopathy was present in 3 cases- tender matted lymphadenitis was present  
 
in 1 case of scrofuloderma and  a case of warty TB over right knee joint and non tender  
 
ipsilateral cervical lymphadenopathy was present in 1 case of lupus vulgaris involving  
 
right forearm.  
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INCIDENCE AND PERCENTAGE OF VARIOUS MORPHOLOGICAL 
TYPES OF CUTANEOUS TB 
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Clinical types Cases number(n) 
total cases - 30 
Percentage of total 
cases 
Warty TB 14 46.66 
Lupus vulgaris 9 30 
Scrofuloderma 2 6.66 
Papulonecrotic tuberculid 2 6.66 
Lichen Scrofulosorum 1 3.33 
Erythema nodosum 2 6.66 
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AGE DISTRIBUTION OF CASES 
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Age 
group(years) 
Case number(n) Percentage of 
total cases 
Less  than 10 1 3.33 
11 – 20 6 20 
21 - 30 8 26 
31 – 40 5 16.66 
41 – 50 4 13.33 
More than 50          6 20 
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SEX DISTRIBUTION OF VARIOUS MORPHOLOGICAL TYPES OF 
CUTANEOUS TB 
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Clinical types Male Female 
Warty TB 10 4 
Lupus vulgaris 4 5 
Scrofuloderma 1 1 
Papulonecrotic 
tuberculid 
1 1 
Lichen 
Scrofulosorum 
1 - 
Erythema 
nodosum 
- 2 
 
 
DISTRIBUTION OF INVOLVED SITES 
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Anatomical site Case number(n) 
(Total cases – 30) 
Percentage of total 
cases 
Face 5 16.6 
Trunk 3 10 
Limbs & buttocks 22 73.3 
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PLAQUE TYPE OFWARTY TUBERCULOSIS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                LUPUS VULGARIS  
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SPOROTRICHOID FORM OF SCROFULODERMA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SCROFULODERMA WITH DACTYLITIS 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
58 
ERYTHEMATOUS PAPULESWITH CENTRAL NECROSIS AND 
VARIOLIFORM SCARS IN A CASE OF PAPULONECROTIC TUBERCULID 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCRETE, SKIN COLOURED ,SCALY PAPULES IN A CASE OF LICHEN 
SCROFULOSORUM 
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ERYTHEMA NODOSUM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
WARTY TUBERCULOSIS 
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LUPUS VULGARIS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
WARTY TUBERCULOSIS WITH TUBERCULOUS LYMPHADENITIS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
61 
Section showing numerous Langhans giant cells and ill-formed tuberculoid 
granulomas in upper dermis - Lupus vulgaris 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Section showing septal panniculitis – Erythema nodosum 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Section showing tuberculoid granulomas in mid dermis – Warty tuberculosis 
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Section showing ill-formed epitheloid cell granuloma - scrofuloderma 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Section stained with Ziehl-Neelson stain showing AFB in a case of 
scrofuloderma 
 
63                                                                         
 
 
 
Section showing pseudoepitheliomatous hyperplasia in a case of Warty TB 
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DISCUSSION 
 
 
Tuberculosis can involve any organ or tissue of the body including skin. Patients with  
 
cutaneous  TB present with diverse forms ranging from single, smooth papule to  
 
disseminated, eruptive papules, verrucous or vegetative plaques, ulceration, sinus tracts.  
 
Acute military TB occurs in patients with severe immunosuppression. Lupus vulgaris and  
 
scrofuloderma are seen in patients with less immunosuppression. Warty TB is a localized  
 
form, seen in immunocompetant individuals.  
 
  
                   In previous studies by Bannerjee47, the incidence of lupus vulgaris to be  
 
38.29%, warty tuberculosis was 19.14%, scrofuloderma  was 14.89%, gumma was 12.76%  
 
and these results were consistent with Khan et al48 , who also found lupus vulgaris as the  
 
commonest followed by warty tuberculosis and scrofuloderma. Singh and Kumar et al also  
 
found lupus vulgaris as the commonest form. Wong et al 49found warty tuberculosis as  the  
 
commonest form(46%), followed by lupus vulgaris (22%) 
                                    
                        
                      In our study, which included 30 cases, warty tuberculosis was the  
 
commonest form(46.6%), followed by lupus vulgaris(30%). This correlated with the study  
 
by Wong et al49.  Men were most commonly found to be affected than women and the  
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incidence in males was 56.6% and in females 43.3%. Warty TB was found to be common  
 
in males,the incidence being 33.3% and lupus vulgaris was found to be more common in  
 
females the incidence being 16.6% is correlated  with Singh and kumar et al50. 
 
 
                       Out of 14 cases of warty TB, 78% patients showed classical tuberculoid  
 
granulomas in the mid dermis and epidermal changes were present in 70% cases. Patients  
 
with lupus vulgaris classic epidermal changes were present in 75% cases and Langhans  
 
giant cells could be seen in 82% cases. Amongst the 2 cases of scrofuloderma, 1 case  
 
showed ulceration with tuberculoid granulomas and AFB could be demonstrated by special  
 
staining and this picture was consistent with that described by Lever51.  
 
   
                    Other than the classical pattern of epitheloid granuloma, Langhans giant cells,  
 
caseous necrosis, several other patterns have been described and should be looked for.  
 
These patterns include abscess, diffuse infiltration of histiocytes, panniculitis, phlebitis,  
 
nonspecific chronic inflammation, naked non necrotic sarcoidal granuloma, rheumatoid  
 
like nodules. In our cases panniculitis was present in 2 cases of erythema nodosum. There  
 
was nonspecific histopathological picture in one case of scrofuloderma with showed  
 
chronic lymphohistiocytic infiltrate and this has been reported by Santa cruz and Strayer in  
 
their study52. 
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Most common site of involvement was the lower extremity. Wong et al reported that knees  
 
and buttocks were the common sites involved in TBVC, similar to the studies by singh. In  
 
our study, 21 – 30 years age group was the most commonly affected, which was also  
 
noticed in studies by Sathyanarayanan and Wong53. 
 
 
 
There was no association with HIV infection in the cases studied. Past history of  
 
pulmonary tuberculosis was present in 3 patients.  Chest x-ray findings consistent with  
 
tuberculosis were present in 10 cases and raised ESR and Mantoux positivity were present  
 
in almost all cases. Most cases belonged to a lower socio economic status , the increased  
 
risk probably attributed to over crowding , poor hygiene andmalnutrition. 
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CONCLUSION 
 
 
Following were the conclusions derived from this study, which included 30 cases 
 
 
¾ Warty tuberculosis was the commonest type followed by lupus vulgaris. 
 
 
¾ There was an increased incidence of warty tuberculosis among males and lupus vulgaris  
 
     among females. 
 
 
¾ Majority of the patients belonged to 20-30 years age group. 
 
 
¾ Clinicopathological correlation was present in all cases except one case of scrofuloderma. 
 
 
¾ Most of the patients belonged to low socioeconomic status, the risk probably due to over  
 
 
     crowding, poor hygiene and malnutrition. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
68 
BIBLIOGRAPHY 
 
 
1.  Moschella SL. Mycobacterial infections. In:Moschella SL, Hurley HJ, eds.     
 
    Dermatology. 2nded. London: WB Saunders  
 
2. Bravo FG, Gotuzzo E. Cutaneous tuberculosis,clin Dermatol 2001:25:173-180  
 
3. Tuberculosis .A comprehensive clinicai reference edited by H.Siman Schaff 
 
4. Harrison’s principles of internal Medicine. Mycobacterial diseases: Tuberculosis: Mario  
 
   C.Ravigkone, Richard  J.O.Brien 1006 - 1023 
 
5. Lever WF, Schaumberg-Lever G. Histopathology of the skin, 7th edn. Philadelphia:   
     
    Lippincott,   1990: 326 - 32 
 
 
6. Beyt BE, Ortbals DW, Santa Cruz et al. Cutaneous mycobacteriosis: analysis of 34 cases  
 
    with a   new classification  of the disease. Medicine 1981:60:95-109. 
 
7. Kumar B.Rai, kaur et al. childhood cutaneous tuberculosis; a study over 25 years from  
 
    northern  India. Int j Dermatol 2001:40:26-32 
 
8.chang LY Lo kk. Cutaneous tuberculosis in Hongkong:10year retrospective study. Int j  
 
   Dermatol  1995:34:26-9 
 
9. Wong KO lee, chui SS. Tuberculosis of the skin in Hong Kong(a review of 160 cases).  
 
    Br J Dermatol 1968;80:424 - 9 
 
 
 
 
 
 
69 
 
 
10.Bolgert M. La tuberculose cutanee. Historique, clinique et evolution therapeutique.  
 
    Semin Hosp  paris 1967; 43 ,868 – 88 
 
         11.Nenoff P, Rytter S, Schubert H. Multilocular inoculation tuberculosis of the skin after  
 
    stay in   Africa: detection by mycobacterial DNA using polymerase chain reaction.Br J       
     
    Dermatol 2000;   143: 226 – 8 
 
12.Goette DK, Jacobson KW, Doty RD. Primary inoculation tuberculosis of the skin. Arch  
 
      Dermatol 1979; 114:567-9 
 
13 .Miller FJW, Cashman JM. Peripheral tuberculosis lymphadenitis associated with a  
 
      visible  primary focus. Lancet 1955; i: 1286-9 
 
14. Lundgren R, Norman E, Asbert I. Tuberculosis infection transmitted at autopsy.     
 
     Tubercle 1987:68:147-50. 
 
15.wong KO, Lee KP, Chin SF.Tuberculosis of skin in Hong kong. Br j Dermatol  
 
     1968:80:424-9. 
 
16.Goh YS, Ong BH,Rajan VS.Tuberculosis cutis in Singapore: a two year  
 
     experience.Sing Med J  1974:15;223-6. 
 
17.lizwa O ,Alba S, Tagami H. Tuberculosis verrucoso cutis in a tumour like form. Br j  
 
     Dermatol  1991:125:79-80. 
 
        18. Massellis P, Gasparini G, Caputo R et al. Tuberculosis verrucosa cutis which remained  
 
    undiagnosed for forty three years. Dermatology 1995;191:145-8. 
 
19.Tur E, Brenner S, Meiron Y. Scrofuloderma(tuberculosis colliquativa cutis). Br J  
 
     Dermatol  1996; 134: 350 – 2. 
 
70 
 
 
 
20. Sehgal VN, Srivastava G, Khurana VK et al. An appraisal of epidemiologic, clinical,  
 
     bacteriologic, histopathologic and immunologic parameters in cutaneous  
 
     tuberculosis.Int J    Dematol 1987;26:521-6 
 
         21. Ramesh V, Misra RS, Jain RK, Secondary tuberculosis of the skin: clinical features and  
 
     problems in laboratory diagnosis. Int J Dematol 1987;26:578-81 
 
 
22. Kumar B, Rai R, Kaur I et al. Childhood cutaneous tuberculosis: a study over 25years  
 
      from  northern India. Int J Dematol 2001;40:26-32 
 
23. Yates VM, Ormerod LP. Cutaneous tuberculosis in Blackburn district(U.K.): a 15year  
.  
     prospective series. Br J Dematol 1997;136:483 – 9 
 
24. Ratcliff DP. Tuberculosis of the mandible. Br Dent J 1973;135:122-4 
 
25. Sasmaz R, Altinyazar HC, Tatlican S et al.Recurrent lupus vulgaris following repeated  
 
     BCG  vaccination J Dematol 2001;28:762-4 
 
26. Sehgal VN, Waugh SA. Cutaneous tuberculosis current concepts. Int J Dematol  
 
     1990;29: 237 – 52 
 
         27. Libraty DH, Byrd TF. Cutaneous miliary tuberculosis in the AIDS era: case report and  
 
     review.  Clin Infect Dis 1996; 23: 706 – 10 
 
28. Thami GP, Kaur S, Kanwar AJ et al. Lichen scrofulosorum: a rare manifestation of a  
 
      common  disease. Pediatr Dermatol 2002; 19: 122-6 
 
 
71 
 
 
 
29. Victor T, Jordaans HF, van Niekerk DJ et al. Papulonecrotic tuberculid. Identification  
 
       of   Mycobacterium tuberculosis DNA by polymerase chain reaction. Am J  
 
      Dermatopathol 1992;   14: 491 - 5 
 
30. Thami GP, Kaur S, Kanwar AJ et al. Lichen scrofulosorum: a rare manifestation of  
 
     a common disease. Pediatr Dermatol 2002; 19: 122 - 6 
 
           31. Pautrier LM. Tuberculosis nodulaire dermique a petits nodules. In: Darier J, ed.  
 
     Nouvelle Pratique Dermatologique, III. Paris: Masson, 1936; 6: 19-30. 
 
 32. Bazin APE. 2nd edition. Paris; Delahaye.1861:146. 
 
33. Schneider FW Jordan HF. The histopathological spectrum of erythema induratum  
 
      of Bazin.Am J Dermatol 1997;18;322-323.  
 
34. Chen YH, Yan JJ, Choa SC et al. Erythema induratum: a clinicopathological and  
 
       polymerase chain reaction study. 
 
35. Forstrom L, Hannuksela M. Antituberculosis treatment of erythema induratum  
 
      Bazin. Acta Derm Venereol 
 
36. Fiewel M, Munro DD. Diagnosis and treatment of erythema induratum. 
 
          37. Aggarwal P, Singal A, Bhattacharya SN, Mishra K. Comparison of  
 
     the radiometric BACTEC 460 TB culture system and Lφwenstein-Jensen  
 
     medium for the isolation of mycobacteria in cutaneous tuberculosis and their  
 
     drug susceptibility pattern. Int J Dermatol 2008;47:681-7 
 
 
 
 
72 
 
 
 
38.Cutler RR, Baithun SI, Doran HM, Wilson P. Association between the  
 
     histological diagnosis of tuberculosis and microbiological findings. Tuber Lung  
 
     Dis 1994;75:75-9 
 
39. Sehgal VN, Srivastava G, Khurana VK. An appraisal of epidemiologic,  
 
     clinical-bacteriologic, histopathologic, and immunologic parameters in  
 
      cutaneous tuberculosis. Int J Dermatol 1987;26:521-6. 
 
40. Pinto osis with leprJ, Pal GS, Kamath N. Cutaneous tuberculosy. Indian J  
 
      Dermatol Venereol Leprol 1991;57:303-4. 
 
41. . Farina MD, Gegundez MI, Pique E, etal. Cutaneous tuberculosis: A clinical,  
 
      histopathologic,and bacteriologic study. J Am Acad Dermatol 1995; 33: 433-440. 
 
42.Grare M, Derelle J, Dailloux M, Laurain C. Difficulties of TB diagnosis in  
 
     children: QuantiFERON TB Gold In-Tube as useful tool. Arch Pediatr 2010;17:77-85. 
 
43.Ramam M, Tejasvi T, Manchanda Y, Sharma S, Mittal R. What is the appropriate  
 
     duration of a therapeutic trial in cutaneous tuberculosis? Further observations. Indian J  
 
     Dermatol Venereol Leprol 2007;73:243-6 
 
44. Treatment of tuberculosis: guidelines. 4 th ed. Geneva: World Health Organization,  
 
      2009 (WHO/HTM/TB/2009.420) 
 
45. Pandhi D, Reddy BSN, Chowdhary S, KhuranaN. Cutaneous tuberculosis in Indian  
 
     children: 
. 
 
 
 
73 
 
 
46. Zerrin B, Ekmekçi TR, Köslü A. Incidence of cutaneous tuberculosis in patients with  
 
     organ  tuberculosis.Int J Dermatol 2003; 42: 197-200 
 
         47.Bannerjee BN. Tuberculosis of the skin and its relation to pulmonary tuberculosis. Ind J 
     Dermatol 1957; 2: 69-72. 
48.Khan Y, Anwar J, Iqbal P, Kumar A. CutaneousTuberculosis A study of ten cases. J    
     Pak Asso Derma 2001; 11: 6-10. 
49.Wong KO, Lee KP, Chiu SF. Tuberculosis of theskin in Hong Kong: a review of 160  
     cases. Br J Dermatol 1968; 80: 424-42. 
50. Kumar B, Muralidhar S. Cutaneous tuberculosis:a twenty-year prospective study. The  
     International Journal of Tuberculosis and Lung Disease1999; 3: 494-500. 
            51. Lever WF, Schaumberg-Lever G. Histopathology of the skin, 7th edn. Philadelphia:      
 
                Lippincott,  1990: 326 – 32 
  
52.shuzter and Strayer . cutaneous tuberculosis: epidemiology andmorphological types  
 
53. Satyanarayan BV. Tuberculoderma- a brief reviewtogether with statistical analysis and  
 
      observations.Ind J Dermatol Venereol 1963;29:25-42. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
74 
 
 
ANNEXURES 
 
 
                                                 PROFORMA 
 
 
Name      Age      Sex 
 
Occupation 
 
Address 
 
Percapita income  
 
Complaints 
 
Duration 
 
H/O evening rise of temperature 
 
H/O cough with expectoration 
 
H/O loss of weight and appetite 
 
H/O trauma 
 
         Past history - Diabetes/ Hypertension/ Tuberculosis 
 
 
Family history 
 
 
Personal history 
 
 
Treatment history 
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  General examination: 
 
 
Built 
 
Nourishment 
 
Febrile 
 
Pallor 
 
Icterus 
 
Clubbing 
 
Lymphadenopathy 
 
PR-  BP- 
 
CVS 
 
RS 
 
P/A 
 
CNS 
 
 
Dermatological examination: 
 
Number of lesions 
 
Site 
 
Size 
 
Shape 
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Surface 
 
Colour 
 
consistency 
 
Nature of lesion 
 
Skin surrounding the lesion 
 
Expression of pus from the lesion on manipulation 
 
Diascopy -  presence or absence of apple-jelly nodules 
 
Probe test – probe can or cannot be passed through the lesion 
 
Mucosal involvement 
 
Nails 
 
Hair 
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MASTER CHART 
 
 
 
s.no Name Age Sex Status Mantoux ESR Chest   
x-ray 
HIV 
status 
H/O 
TB 
Biopsy AFB 
stain 
Diagnosis 
1. Murali 15 M Middle + 15 Normal Non 
reactive 
- Consistent 
with TBVC 
- TBVC 
2. Karthik 25 M Middle + 20 Hilar 
adenitis 
Non 
reactive 
- Consistent 
with TBVC 
- TBVC 
3. Sarala 42 F Low + 15 Normal Non 
reactive 
- Consistent 
with  Lupus 
vulgaris 
- Lupus 
vulgaris 
4. Ramachandran 28 M Low + 25 Normal Non 
reactive 
- Consistent 
with PNT 
- Papulonecr
otic 
tuberculid 
5. Navab khan 26 M Low + 15 Normal Non 
reactive 
- Consistent 
with Lupus 
vulgaris 
- Lupus 
vulgaris 
6. Hari babu 20 M Low + 10 Normal Non 
reactive 
- Consistent 
with TBVC 
- TBVC 
7. Selvi 18 F Low - 45 Apical 
opacity 
Non 
reactive 
- Inconsistent + Scrofulode
rma 
8. Janaki raman 36 M Middle + 25 Normal Non 
reactive 
- Consistent 
with TBVC 
- TBVC 
9. Kalai priyan 14 M Low + 10 Normal Non 
reactive 
- Consistent 
with TBVC 
- TBVC 
10. Kasiammal 54 F Low + 15 Apical 
opacity 
Non 
reactive 
+ Septal 
panniculitis 
- Erythema 
nodosum 
11. Jothi 55 M Low + 45 Pneumo
nitis 
Non 
reactive 
- Consistent 
with 
scrofuloder
ma 
- Scrofulode
rma 
12. Manohar 11 M Middle + 10 Normal Non 
reactive 
- Consistent 
with TBVC 
- TBVC 
13. Saroja 54 F Middle + I5 Normal Non 
reactive 
- Consistent 
with TBVC 
- TBVC 
14. Raja 45 M Low + 10 Apical 
cavity 
Non 
reactive 
+ Consistent 
with Lupus 
vulgaris 
- Lupus 
vulgaris 
15. kadaliamma 64 F Low + 25 Old 
healed 
PT 
Non 
reactive 
- Consistent 
with PNT 
- Papulonecr
otic 
tuberculid 
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MASTER CHART 
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s.no Name Age Sex Status Mantoux ESR Chest   
x-ray 
HIV 
status 
H/O 
TB 
Biopsy AFB 
stain 
Diagnosis 
16. Rajesh 28 M Low + 20 Normal Non 
reactive 
- Consistent 
with TBVC 
- TBVC 
17. Nagarajan 18 M Low + 15 Normal Non 
reactive 
- Consistent 
with Lupus 
vulgaris 
- Lupus vulgaris 
18. Pradeep 10 M Low + 10 Hilar 
adenitis 
Non 
reactive 
- Tuberculoid 
granulomas  + 
- Lichen 
scrofulosorum 
19. Vijaya 30 F Middl
e 
+ 10 Apical  
opacity 
Non 
reactive 
- Consistent 
with Lupus 
vulgaris 
- Lupus vulgaris 
20. Velaiyah 5o M Low + 10 Healed 
PT 
Non 
reactive 
+ Consistent 
with TBVC 
- TBVC 
21. Saraswati 52 F Low + 10 Normal Non 
reactive 
- Consistent 
with Lupus 
vulgaris 
- Lupus vulgaris 
22. Velu 45 M Low - 15 Normal Non 
reactive 
- Consistent 
with TBVC 
- TBVC 
23. Devi 28 F Low + 5 Normal Non 
reactive 
- Consistent 
with TBVC 
- TBVC 
24. Selvam 56 F Low + 35 Hilar 
adenitis 
Non 
reactive 
- Septal 
panniculitis 
- Erythema 
nodosum 
25. Ramesh 22 M Middl
e 
+ 25 Normal Non 
reactive 
- Consistent 
with Lupus 
vulgaris 
- Lupus vulgaris 
26. Arjunan 36 M Low + 15 Normal Non 
reactive 
- Consistent 
with TBVC 
- TBVC 
27. Lakshmi 34 F Low + 10 Normal Non 
reactive 
- Consistent 
with Lupus 
vulgaris 
- Lupus vulgaris 
28. Kannagi 40 F Low + 20 Normal Non 
reactive 
- Consistent 
with Lupus 
vulgaris 
- Lupus vulgaris 
29. Rama laxmi 32 F Low + 15 Normal Non 
reactive 
- Consistent 
with Lupus 
vulgaris 
- Lupus vulgaris 
30. Raju 25 M Low + 15 Normal Non 
reactive 
- Consistent 
with Lupus 
vulgaris 
- Lupus vulgaris 
 
 
 
INFORMED CONSENT FORM 
 
 
 
I have been fully explained by the doctors about the study and I also give my consent to 
undergo  
 
the investigations done in this study. 
 
 
Station: Chennai.                                                                           Patient’s signature 
 Date: 
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